Search results - ORA - Oxford University Research Archive

« Previous | 1 - 10 of 13 | Next »

1

Journal article

Outcome of azacitidine therapy in acute myeloid leukemia is not improved by concurrent vorinostat therapy but is predicted by a diagnostic molecular signature

Craddock, C, Houlton, A, Quek, L, et al.
2017-08-01

2

Journal article

Acute leukemias in children with Down syndrome.

Zwaan, M, Reinhardt, D, Hitzler, J, et al.
2008-02-01

3

Journal article

Acute myeloid leukaemia blast cells with a tyrosine kinase domain mutation of FLT3 are less sensitive to lestaurtinib than those with a FLT3 internal tandem duplication.

Mead, A, Gale, R, Kottaridis, P, et al.
2008-05-01

4

Journal article

Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer.

Nathan, P, Zweifel, M, Padhani, A, et al.
2012-06-01

5

Journal article

Combination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude mice.

Nölting, S, Giubellino, A, Tayem, Y, et al.
2014-07-01

6

Journal article

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.

Blick, C, Hall, P, Pwint, T, et al.
2012-08-01

7

Journal article

The diagnosis and medical management of advanced neuroendocrine tumors.

Kaltsas, G, Besser, G, Grossman, A
2004-06-01

8

Journal article

Contribution of granulocyte colony-stimulating factor to the acute mobilization of endothelial precursor cells by vascular disrupting agents.

Shaked, Y, Tang, T, Woloszynek, J, et al.
2009-10-01

9

Journal article

Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors.

Macaulay, V, Middleton, M, Protheroe, A, et al.
2013-03-01

10

Journal article

Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.

Mele, T, Generali, D, Fox, S, et al.
2010-10-01

TO TOP